DAVIES Rebecca Jaine,GANDERTON David,LEWIS David Andrew,MEAKIN Brian John,CHURCH Tanya Kathleen,BRAMBILLA Gaetano,FERRARIS Alessandra
申请号：
SI200332607
公开号：
SI3536344T1
申请日:
2003.02.26
申请国别(地区):
SI
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical formulation for use in the administration of a long-acting ² 2 -agonist by inhalation. In particular this invention relates to a chemically stable highly efficient formoterol HFA solution formulation to be administered by pressurised metered dose inhalers (pMDIs) characterized by a deep lung penetration. The invention also relates to methods for the preparation of said formulation and to its use in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
